Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Unknown 4Recruiting 2Not yet recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 4Systemic Inflammatory Response Syndrome 1Amenorrhea 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Interventional × Mastectomy, Modified Radical × Clear all
NCT02953184 2017-12-29

Marched Pair Study Conventional Doxorubicin(DOX) Versus Pegylated Liposomal Doxorubicin(PLD) Neoadjuvant Chemotherapy

Jilin University

Phase 2 Unknown
160 enrolled
Breast

Breast Neoplasms

NCT03283345 2017-09-18

Effect of Menstrual Cycle on Traumatic Systemic Response

Kocaeli University

Phase NA Unknown
89 enrolled
Breast

Breast Neoplasms, Systemic Inflammatory Response Syndrome

NCT01503905 2016-05-24

Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase NA Unknown
600 enrolled
Breast

Amenorrhea, Breast Neoplasms

NCT01917578 2013-08-06

BCSMANC

Shandong Cancer Hospital and Institute

Phase 3 Unknown
4 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡